MOUNJARO

Google image searchProduct monograph

Active ingredient

tirzepatide, 7.5 MG/0.5 ML

DIN: 02541076

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-DOSE VIAL

Schedule: Prescription

Company: ELI LILLY CANADA INC

Date: 23-OCT-2023

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
• A10BX — Other blood glucose lowering drugs, excl. insulins (ATC, ATC/DDD)
• A10BX16 — TIRZEPATIDE (ATC/DDD)

Reference brand drug: Mounjaro

External Links for Mounjaro

Search on Google

• Mounjaro side effects
• Mounjaro dosage
• tirzepatide side effects
• tirzepatide dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find mounjaro photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.